OCPNF News and Press, Olympus Corp From 02/10/23

Olympus Corporation (OCPNF) Q3 2023 Earnings Conference Call Feb 10, 2023, 01:00 AM ET Company Participants Yasuo Takeuchi - President and Chief Executive Officer Chikashi Takeda - Chief Financial Officer Nacho Abia - Chief Operating Officer Stefan Kaufmann - Chief...

Olympus ( OTCPK:OCPNF ): Q3 GAAP EPS of ¥85.04. Revenue of ¥641.55B (+17.2% Y/Y). For further details see: Olympus GAAP EPS of ¥85.04, revenue of ¥641.55B

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The International Growth ACWI ex-US Strategy takes ...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The International Growth EAFE Strategy takes a dive...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The International Growth ADR Strategy takes a diver...

Japanese medical device maker Olympus Corp ( OTCPK:OCPNF ) ( OTCPK:OCPNY ) said Wednesday that the company was taking corrective action to address the concerns raised by the U.S. FDA regarding the production of endoscopes. During surgeries and diagnostic procedures, endoscopes allow d...

The following slide deck was published by Olympus Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Olympus Corporation 2022 Q3 - Results - Earnings Call Presentation

Olympus Corporation (OCPNY) Q3 2022 Earnings Conference Call November 11, 2022 04:00 ET Company Participants Yasuo Takeuchi - President and Chief Executive Officer Chikashi Takeda - Chief Financial Officer Nacho Abia - Chief Operating Officer Stefan Kaufmann ...

Summary Carl Zeiss Meditec recorded strong order growth of 36% YoY in Q3 FY9/2022 results, highlighting strong underlying demand. Operating margins look stable at 20%, driven by an improving sales mix despite ongoing investment in R&D and marketing activities. The shares h...

Summary International growth stocks held up better than value, snapping a two-quarter losing streak, as global recession fears weighed more heavily on companies tied to the broader economy. The Strategy outperformed for the second quarter in a row, thanks in large part to position...